2023 Appeal Enrollment:

November 21st- December 12th

 

The Time is Now! Review your Benefits!

The Open Enrollment period ended November 15th and this was a required enrollment. If you did not enroll, this is your last opportunity to make a change to your current benefits!

If you do not make a change during this enrollment, the benefits elected during the prior enrollment will remain in effect.
If you did not enroll during the initial enrollment and elect not to participate in this appeal enrollment period, your current benefits will terminate December 31, 2022, and you will be automatically (except disability plans, will remain active) assigned to the Cigna SureFit employee only coverage. You will only be able to make a change after this enrollment period if experiencing a qualifying Change in Status.

Voluntary benefits by Transamerica will be offered during the enrollment period, schedule an appointment to learn what is being offered, review your options, and enroll.

If you would like assistance with your enrollment session, and understanding your benefits offerings, schedule an appointment with a Benefits Representative. You can schedule an appointment for in-person (at one of the on-site locations), telephonic and/or virtual enrollment via the Enrollment Assistance Call Center.

Don’t Wait…Schedule Your Appointment Today!

  • Click the button below to schedule your appointment.
  • From the drop-down, select the location you would like to meet with the Benefits Representative on-site or through the Call Center.
  • If you select “Call Center – Telephonic”, a Benefits Representative will call you at the time of your scheduled appointment – the call will originate from 855-632-7748.
  • If you select “Call Center – Virtual”, you must enter an email to receive a link to the appointment. Be prepared to be contacted by the Benefits Representative at the time of your appointment and be sure you are in front of your computer. The Benefits Representative will provide a link to join your Virtual Enrollment Session.